Back
Speaker illustration

Mr Amol Dhamane

Bristol-Myers Squibb, Lawrenceville (United States of America)

Presentations

Anticoagulant treatment patterns and thromboembolic events by tumor type among patients with VTE and cancer

Event: ESC Congress 2022

Topic: Venous Thromboembolism

Session: A journey through vascular diseases

Access
Like
Thumbnail

Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention 1

Access
Like
Thumbnail

Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources